Centiva Capital’s ATRenew RERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.2K Sell
22,008
-19,762
-47% -$87.7K ﹤0.01% 1545
2026
Q1
$196K Buy
41,770
+25,369
+155% +$143K ﹤0.01% 1282
2025
Q4
$86.9K Buy
+16,401
New +$73.5K ﹤0.01% 1089
2025
Q2
– Sell
-17,974
Closed -$52.8K – 1963
2025
Q1
$52.8K Buy
+17,974
New +$52.8K ﹤0.01% 1434
2024
Q4
– Sell
-75,483
Closed -$210K – 2273
2024
Q3
$210K Buy
75,483
+58,413
+342% +$142K ﹤0.01% 1798
2024
Q2
$40.5K Buy
+17,070
New +$37.4K ﹤0.01% 1939

Other funds holding RERE

Centiva Capital's RERE Position: Q2 2026 in Review

Centiva Capital reduced its ATRenew (RERE) stake by 47% in Q2 2026, selling an estimated $87.7K and leaving 22,008 shares worth $85.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Centiva Capital first reported a position in RERE in Q2 2024 and has held it in 6 quarters since. The position peaked at $210K in Q3 2024. 75 funds tracked by Wall St. Rank hold RERE as of Q2 2026.

  • Centiva Capital held 22,008 shares of ATRenew worth $85.2K as of Q2 2026.
  • Centiva Capital sold 19,762 ATRenew shares in Q2 2026, an estimated $87.7K.
  • ATRenew made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1545 holding.
  • Centiva Capital first reported a position in ATRenew in Q2 2024 and has held it in 6 quarters since.
  • Centiva Capital's ATRenew position peaked at $210K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held ATRenew as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.